Combination drugs reduce side-effects
Nature Medicine
November 12, 2012
The combination of two compounds, estrogen and the gut hormone GLP-1, results in a more selective and potent metabolic drug with fewer side effects, according to research published this week in Nature Medicine.
Estrogen, by modulating feeding behavior and energy expenditure, has been suggested as a therapy for obesity and type 2 diabetes; however, it can also cause unwanted effects, such as tumor growth promotion. Matthias Tschop and colleagues circumvent this issue by chemically linking estrogen to the hormone GLP-1 to selectively target metabolically-relevant tissue. The authors note that the conjugated compound also has greater beneficial metabolic effects in obese mice compared to either native compound administered alone."
They conclude that this chemical approach may lead to other safer drug combinations, such as widely used glucocorticoids, to treat a variety of different diseases. Long-term toxicological studies are needed however, to ensure that negative effects on cell types that express receptors for both GLP-1 and estrogen, such as pancreatic beta cells, does not occur.
doi: 10.1038/nm.3009
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Cancer: Signatures of structural genomic variation in cancerNature